| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/15/2014 | CN103505434A Cefuroxime axetil tablet and preparation method thereof |
| 01/15/2014 | CN103505430A Cefixime tablets |
| 01/15/2014 | CN103505411A Ornidazole injection |
| 01/15/2014 | CN103505410A Single-dosage gatifloxacin eye drop and preparation method thereof |
| 01/15/2014 | CN103505407A Multi-chamber bag packaged moxifloxacin hydrochloride/glucose aqueous solution preparation |
| 01/15/2014 | CN103505406A Nifuratel gel and preparation method thereof |
| 01/15/2014 | CN103505404A Oral liquid preparation with roxithromycin as active component |
| 01/15/2014 | CN103505398A Forsythia leaf facial mask |
| 01/15/2014 | CN103505395A Forsythia leaf traditional Chinese medicinal toothpaste |
| 01/15/2014 | CN103504703A Pure traditional Chinese medicine health-care insole |
| 01/15/2014 | CN103504481A Electronic cigarette with antibacterial layer cigarette holder |
| 01/15/2014 | CN103504069A Dahurian patrinia herb heat-clearing tea |
| 01/15/2014 | CN103503867A Production method for strong glutaraldehyde solution |
| 01/15/2014 | CN103055225B Traditional Chinese medicine for treating drug resistant pulmonary tuberculosis and preparation method of traditional Chinese medicine |
| 01/15/2014 | CN103040804B Norwogonin and application thereof to preparation of medicines for treating acinetobacter baumannii infection |
| 01/15/2014 | CN103013743B Preparation method of broadleaf holly leaf healthcare wine |
| 01/15/2014 | CN102988968B Vaccine utilizing vibrio anguillarum flagellin and application thereof |
| 01/15/2014 | CN102885995B Traditional Chinese medicine for treating acute lymphadenitis |
| 01/15/2014 | CN102885785B Adriamycin-containing nanometer medicament microspheres and preparation method thereof |
| 01/15/2014 | CN102772732B Medicine composition for treating chronic liver disease |
| 01/15/2014 | CN102772595B Traditional Chinese composition for treating chronic hepatitis B |
| 01/15/2014 | CN102772573B Oral liquid for strengthening immunity and resisting virus and preparation method thereof |
| 01/15/2014 | CN102716228B Traditional Chinese medicine composition for treating acute and chronic viral hepatitis and preparation method for traditional Chinese medicine composition |
| 01/15/2014 | CN102716223B Chinese medicinal composition for treating upper respiratory tract infection and preparation method thereof |
| 01/15/2014 | CN102716098B Cefditoren pivoxil liposome solid preparation |
| 01/15/2014 | CN102716082B Cefoxitin sodium liposome injection |
| 01/15/2014 | CN102641489B Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof |
| 01/15/2014 | CN102617562B Thiazole derivant and preparation method and use thereof |
| 01/15/2014 | CN102579588B Heat clearing and exterior syndrome relieving capsule |
| 01/15/2014 | CN102552476B Quality control method for Rosa laevigata root |
| 01/15/2014 | CN102552369B Lon icera japonica Thunb leaf extractive serving as anti-porcine reproductive and respiratory syndrome viral agent |
| 01/15/2014 | CN102397498B Chinese medicinal syrup for treating whooping cough in children |
| 01/15/2014 | CN102260667B Preparation of cell microparticle-siRNA composite and application thereof in treating AIDS |
| 01/15/2014 | CN102228546B Traditional Chinese medicine preparation for treating viral pneumonia and preparation method and application thereof |
| 01/15/2014 | CN102210630B System and method for preparing nosiheptide premix particles |
| 01/15/2014 | CN102191255B Preparation and application of recombinant plectasin |
| 01/15/2014 | CN102160888B Medicine for treating mycotic vaginitis |
| 01/15/2014 | CN101781335B New tenofovir disoproxil fumarate crystal and preparation method thereof |
| 01/14/2014 | US8629317 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof |
| 01/14/2014 | US8629155 Aspartyl protease inhibitors |
| 01/14/2014 | US8629150 Compounds for the treatment of hepatitis C |
| 01/14/2014 | US8629142 Modulators of toll-like receptors |
| 01/14/2014 | US8629117 Method for stimulating the immune system |
| 01/14/2014 | US8628807 Negatively charged polysaccharide derivable from aloe vera |
| 01/14/2014 | US8628784 Adjuvant systems and vaccines |
| 01/14/2014 | CA2701025C Anti-bacterial pyrocatechols and related methods |
| 01/14/2014 | CA2669019C Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 01/14/2014 | CA2650798C Inhibitors of human immunodeficiency virus replication |
| 01/14/2014 | CA2528849C Quinoline derivatives as antibacterial agents |
| 01/14/2014 | CA2426312C Compositions and methods for modulating rsv infection and immunity |
| 01/14/2014 | CA2373375C Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 01/13/2014 | CA2821001A1 Use of probiotic bacterial strains as a prophylactic tool against uterine infections in pregnant female ruminants |
| 01/09/2014 | WO2014008285A1 Inhibitors of hepatitis c virus |
| 01/09/2014 | WO2014008248A2 Compositions and methods for treating and inhibiting viral infections |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007303A1 Therapeutic method and remedy for htlv-1-associated myelopathy patients |
| 01/09/2014 | WO2014006576A1 Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof |
| 01/09/2014 | WO2014006253A1 Composition for treating bacterial infections of the skin and mucous membranes |
| 01/09/2014 | WO2014006066A1 Triazole compounds as antivirals |
| 01/09/2014 | WO2013172741A3 Fluoro-substituted (3r, 4r, 5s)-5-guanidino-4-acylamino-3-(pentan-3-yloxy) cyclohexene-1-carboxylic acids, esters thereof and a method for the use thereof |
| 01/09/2014 | WO2013164652A3 Microspheres for treating helicobacter pylori infections |
| 01/09/2014 | WO2012174622A8 Plant extract obtained from kielmeyera aureovinosa which has antibiotic activity, isolated chemical compound, compositions comprising same, uses thereof and methods for preventing and treating bacterial infections |
| 01/09/2014 | US20140012006 Benzimidazole compound crystal |
| 01/09/2014 | US20140011885 Organic Compounds |
| 01/09/2014 | US20140011869 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
| 01/09/2014 | US20140011837 Compositions and methods for treating warts associated with viral infections |
| 01/09/2014 | US20140011829 Artemisinin-Based Combination Therapy For Treating Viral Mediated Disease |
| 01/09/2014 | US20140011815 Fitness assay and associated methods |
| 01/09/2014 | US20140011764 Anti-Viral Pyrimidine Nucleoside Analogues |
| 01/09/2014 | US20140011756 Method for Treatment of Inflammation |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | US20140010843 Method of detoxification |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | CA2878292A1 Potentiation of antibiotic treatment with a protein-lipid complex |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | CA2877948A1 Paramyxovirus and methods of use |
| 01/09/2014 | CA2877848A1 Therapeutic method and medicament for htlv-1 associated myelopathy (ham) |
| 01/09/2014 | CA2877335A1 Method of treating retroviral infections and related dosage regimes |
| 01/09/2014 | CA2877005A1 Inhibitors of hepatitis c virus |
| 01/09/2014 | CA2874815A1 Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof |
| 01/08/2014 | EP2682463A1 Bacteriocin derived from lactobacillus rhamnosus |
| 01/08/2014 | EP2682399A1 Novel macrolide intermediate and novel production process |
| 01/08/2014 | EP2682397A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
| 01/08/2014 | EP2682387A2 C7-fluoro substituted tetracycline compounds |
| 01/08/2014 | EP2682386A1 Novel vitamin d receptor modulator with partial agonist activity |
| 01/08/2014 | EP2682127A1 Vaccine |
| 01/08/2014 | EP2681208A1 Antimicrobial/adjuvant compounds and methods |
| 01/08/2014 | EP2680866A1 Materials and methods for treating conditions associated with pathogenic biofilm |
| 01/08/2014 | EP2680860A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| 01/08/2014 | EP2680859A2 Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection |
| 01/08/2014 | EP2680857A1 Oleyl phosphocholine for the treatment of mycosis |
| 01/08/2014 | EP2680852A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/08/2014 | CN103502275A Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same |
| 01/08/2014 | CN103502264A Peptide which can induce antibody capable of recognizing stereostructure of HIV |
| 01/08/2014 | CN103501798A Pandemic influenza antiviral agent |
| 01/08/2014 | CN103501638A Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |